MyFinsight
Home
Blog
About
Contact
Download
Download image
Net comprehensive
loss
-$11,743,745
(-26.08%↓ Y/Y)
Net loss
-$11,131,448
(-12.37%↓ Y/Y)
Foreign currency
translation adjustment
-$612,297
(-203.56%↓ Y/Y)
Total other expenses
-$7,783,684
Loss from operations
-$3,347,764
(7.17%↑ Y/Y)
Change in the fair value
of obligation to...
$1,487,328
(143.11%↑ Y/Y)
Gain on write-off of
accounts payable and...
$410,430
Foreign exchange gain
$66,252
Loss on impairment of
investment
$4,518,127
Interest expense
$1,958,785
(-13.48%↓ Y/Y)
Other expense
$1,930,000
Gross loss
-$2,084,908
(28.96%↑ Y/Y)
Total operating
expenses
$1,262,856
(88.11%↑ Y/Y)
Change in the fair value
of derivative...
-$850,152
(-909.18%↓ Y/Y)
Imputed interest
expense
$490,630
Revenue
$1,362,163
(66.09%↑ Y/Y)
Cost of goods sold
$3,447,071
(-8.20%↓ Y/Y)
General and
administrative
$489,641
(319.79%↑ Y/Y)
Professional fees
$469,690
(7.85%↑ Y/Y)
Royalty expense
$303,525
Back
Back
Income Statement
source: myfinsight.com
CANNAPHARMARX, INC. (CPMD)
CANNAPHARMARX, INC. (CPMD)